biopharmaceutical love

biopharmaceutical

Definitions

from The American Heritage® Dictionary of the English Language, 5th Edition.

  • noun A drug created by means of biotechnology, generally a protein or nucleic acid rather than a small molecule.

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun Any drug produced using biotechnology

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word biopharmaceutical.

Examples

  • Through this deal, Pfizer for the first time will be looking at sourcing high-margin biopharmaceutical drugs in India, said analyst Sarabjit Kour Nangra of Mumbai-based Angel Broking.

    Pfizer, Biocon in Insulin Licensing Deal Rumman Ahmed 2010

  • Like other traditional drug makers, Bristol-Myers, based in New York, is trying to transform itself into a "biopharmaceutical" company with products and expertise in the protein-based science of biotechnology as well as chemistry-based pills from its conventional drug business.

    Bristol-Myers, Biotech Firm to Develop Cancer Drugs 2008

  • Pergamum AB is a new kind of biopharmaceutical company focusing solely on dermatology and wound healing markets.

    unknown title 2009

  • Johnson & Johnson edged down 0.3% after it said it will buy the 82% of biopharmaceutical company Crucell that it doesn't already own for $2.4 billion.

    GE, Alcoa Lead DJIA Higher Jonathan Cheng 2010

  • During the same period, major biopharmaceutical firms demonstrated strong financial performances.

    America's Innovation Agency: The FDA Margaret A. Hamburg 2011

  • What's new is that the federal government wants most of the biopharmaceutical industry to go away.

    An Ambivalent Case for More Medical Research Spending 2011

  • Ian Read, head of Pfizer's biopharmaceutical businesses, said in an interview that Pfizer has maintained about 30% of the prescriptions for Effexor, but he expects that to drop after Teva's exclusivity ends and more generic competition enters the market.

    Pfizer Profit Declines 70% On Merger, Litigation Costs Thomas Gryta 2010

  • If IPAB lowers reimbursement rates to providers in the Medicare drug benefit, biopharmaceutical researchers will find themselves with fewer resources to investigate new treatments.

    David Mixner: Why The HIV/AIDS Community Should Care About the New Medicare Panel David Mixner 2010

  • The U.S. biopharmaceutical industry accounts for the largest share of global launches of new drugs and the medical-device industry has a positive trade balance, with the value of its exports growing annually.

    America's Innovation Agency: The FDA Margaret A. Hamburg 2011

  • Consider that the U.S. biopharmaceutical and medical-device sectors dominate their global industries.

    America's Innovation Agency: The FDA Margaret A. Hamburg 2011

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.